FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2108280177> ?p ?o ?g. }

• W2108280177 endingPage "372" @default.
• W2108280177 startingPage "367" @default.
• W2108280177 abstract "Chronic lymphocytic leukemia (CLL) is a B-cell disorder, but it is also associated with abnormalities in T-lymphocyte function. In this study we examine changes in T-lymphocyte CD39 and CD73 expression in patients with CLL.Blood samples were drawn from 34 patients with CLL and 31 controls. The cells were stained for CD3, CD4, CD8, CD19, CD39, and CD73 and analyzed by flow cytometry.Overall, patients with CLL had a higher percentage of CD39(+) T lymphocytes than did controls. The percentage of cells expressing CD39 was higher in both CD4(+) cells and CD8(+) cells. Higher CD3/CD39 expression was associated with a later disease stage. No correlations between T-lymphocyte CD39 levels and CD38 or Zap-70 expression were observed. In contrast, the percentage of T lymphocytes and B lymphocytes that expressed CD73 was decreased in patients with CLL. Average B-lymphocyte CD73 expression was decreased in CLL because the majority of CLL clones were CD73. However a minority of CLL clones were CD73(+), and patients with CD73(+) clones tended to have earlier stage disease.T-lymphocyte CD39 and CD73 expression may be useful prognostic markers in patients with CLL. Expression of CD73 on the malignant cell population in CLL may be a marker of better prognosis." @default.
• W2108280177 created "2016-06-24" @default.
• W2108280177 creator A5000844080 @default.
• W2108280177 creator A5013974745 @default.
• W2108280177 creator A5035532011 @default.
• W2108280177 creator A5039797196 @default.
• W2108280177 creator A5057720141 @default.
• W2108280177 creator A5065051001 @default.
• W2108280177 creator A5082092302 @default.
• W2108280177 creator A5085398286 @default.
• W2108280177 date "2011-08-01" @default.
• W2108280177 modified "2023-10-17" @default.
• W2108280177 title "CD39 Expression on T Lymphocytes Correlates With Severity of Disease in Patients With Chronic Lymphocytic Leukemia" @default.
• W2108280177 cites W1501783126 @default.
• W2108280177 cites W1565276921 @default.
• W2108280177 cites W1831423005 @default.
• W2108280177 cites W1988951550 @default.
• W2108280177 cites W1993334366 @default.
• W2108280177 cites W2000297648 @default.
• W2108280177 cites W2025419815 @default.
• W2108280177 cites W2038592860 @default.
• W2108280177 cites W2053763669 @default.
• W2108280177 cites W2059177056 @default.
• W2108280177 cites W2077971241 @default.
• W2108280177 cites W2079536751 @default.
• W2108280177 cites W2097191776 @default.
• W2108280177 cites W2098983864 @default.
• W2108280177 cites W2104233494 @default.
• W2108280177 cites W2158602811 @default.
• W2108280177 cites W2167673584 @default.
• W2108280177 cites W2168535576 @default.
• W2108280177 cites W2323490326 @default.
• W2108280177 cites W60865865 @default.
• W2108280177 cites W81150400 @default.
• W2108280177 doi "https://doi.org/10.1016/j.clml.2011.06.005" @default.
• W2108280177 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3590911" @default.
• W2108280177 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21816376" @default.
• W2108280177 hasPublicationYear "2011" @default.
• W2108280177 type Work @default.
• W2108280177 sameAs 2108280177 @default.
• W2108280177 citedByCount "59" @default.
• W2108280177 countsByYear W21082801772012 @default.
• W2108280177 countsByYear W21082801772013 @default.
• W2108280177 countsByYear W21082801772014 @default.
• W2108280177 countsByYear W21082801772015 @default.
• W2108280177 countsByYear W21082801772016 @default.
• W2108280177 countsByYear W21082801772017 @default.
• W2108280177 countsByYear W21082801772018 @default.
• W2108280177 countsByYear W21082801772019 @default.
• W2108280177 countsByYear W21082801772020 @default.
• W2108280177 countsByYear W21082801772021 @default.
• W2108280177 countsByYear W21082801772022 @default.
• W2108280177 countsByYear W21082801772023 @default.
• W2108280177 crossrefType "journal-article" @default.
• W2108280177 hasAuthorship W2108280177A5000844080 @default.
• W2108280177 hasAuthorship W2108280177A5013974745 @default.
• W2108280177 hasAuthorship W2108280177A5035532011 @default.
• W2108280177 hasAuthorship W2108280177A5039797196 @default.
• W2108280177 hasAuthorship W2108280177A5057720141 @default.
• W2108280177 hasAuthorship W2108280177A5065051001 @default.
• W2108280177 hasAuthorship W2108280177A5082092302 @default.
• W2108280177 hasAuthorship W2108280177A5085398286 @default.
• W2108280177 hasBestOaLocation W21082801772 @default.
• W2108280177 hasConcept C10205521 @default.
• W2108280177 hasConcept C114684123 @default.
• W2108280177 hasConcept C159912055 @default.
• W2108280177 hasConcept C167672396 @default.
• W2108280177 hasConcept C203014093 @default.
• W2108280177 hasConcept C2777761686 @default.
• W2108280177 hasConcept C2777938653 @default.
• W2108280177 hasConcept C2778461978 @default.
• W2108280177 hasConcept C2778957590 @default.
• W2108280177 hasConcept C28328180 @default.
• W2108280177 hasConcept C2908647359 @default.
• W2108280177 hasConcept C54355233 @default.
• W2108280177 hasConcept C553184892 @default.
• W2108280177 hasConcept C71924100 @default.
• W2108280177 hasConcept C86803240 @default.
• W2108280177 hasConcept C8891405 @default.
• W2108280177 hasConcept C99454951 @default.
• W2108280177 hasConceptScore W2108280177C10205521 @default.
• W2108280177 hasConceptScore W2108280177C114684123 @default.
• W2108280177 hasConceptScore W2108280177C159912055 @default.
• W2108280177 hasConceptScore W2108280177C167672396 @default.
• W2108280177 hasConceptScore W2108280177C203014093 @default.
• W2108280177 hasConceptScore W2108280177C2777761686 @default.
• W2108280177 hasConceptScore W2108280177C2777938653 @default.
• W2108280177 hasConceptScore W2108280177C2778461978 @default.
• W2108280177 hasConceptScore W2108280177C2778957590 @default.
• W2108280177 hasConceptScore W2108280177C28328180 @default.
• W2108280177 hasConceptScore W2108280177C2908647359 @default.
• W2108280177 hasConceptScore W2108280177C54355233 @default.
• W2108280177 hasConceptScore W2108280177C553184892 @default.
• W2108280177 hasConceptScore W2108280177C71924100 @default.
• W2108280177 hasConceptScore W2108280177C86803240 @default.
• W2108280177 hasConceptScore W2108280177C8891405 @default.
• W2108280177 hasConceptScore W2108280177C99454951 @default.
• W2108280177 hasIssue "4" @default.

• next